Point of Care Respiratory
Acceava hCG Basic II Acceava hCG Urine II Acceava hCG Combo II BioStar OIA STREP B Clearview hCG Dipstick Clearview hCG Cassette Clearview hCG Combo II Clearview 25 hCG Combo RUBELLA-plus
Acceava®, BinaxNOW®, BioStar®, Clearview®, OIA® and RUBELLA-plus® are registered trademarks of the Inverness Medical family of companies.
Clearview hCG Combo II

CLIA Waived procedure availableClearview hCG Combo II is a one-step test for the early detection of the pregnancy hormone, human chorionic gonadotropin (hCG).

Clearly different

Clearview hCG Combo II uses a patented, innovative technology to provide highly sensitive and specific results for pregnancy.

  • Fast: single-step test provides positive results in as little as 1 minute
  • Easy: CLIA-waived (for urine), easy-to-use test
  • Reliable: highly sensitive assay with built-in controls ensures accuracy
  • Flexible: test can be used with either urine or serum samples

 

Clearly better

Early diagnosis with Clearview hCG enables proper planning, which reduces potential risks to the mother and fetus.

  • Earlier detection of pregnancy allows for improved patient care
  • Rapid results help prevent infection or contraindicated treatment

 

Clearview hCG Combo II Test Procedure

Procedure

Add 3 drops of urine or serum to the Sample Well.

Interpretation

Read result in 3 minutes for urine, or 5 minutes for serum. For full instructions, see package insert.

About Pregnancy

Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced by the developing placenta shortly after fertilization. In normal pregnancy, hCG can be detected in both urine and serum as early as 7 to 10 days after conception.1-4 hCG levels continue to rise very rapidly, frequently exceeding 100 mIU/mL by the first missed menstrual period, and peaking in the 100,000-200,000 mIU/mL range about 10-12 weeks into pregnancy.2-4 The appearance of hCG in both the urine and serum soon after conception, and its subsequent rapid rise in concentration during early gestational growth, make it an excellent marker for the early detection of pregnancy.

References

  1. Batzer FR. “Hormonal evaluation of early pregnancy”, Fertil. Steril. 1980; 34(1): 1-13
  2. Catt KJ, ML Dufau, JL Vaitukaitis “Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyte”, J. Clin. Endocrinol. Metab. 1975; 40(3): 537-540
  3. Braunstein GD, J Rasor, H. Danzer, D Adler, ME Wade “Serum human chorionic gonadotropin levels throughout normal pregnancy”, Am. J. Obstet. Gynecol. 1976; 126(6): 678-681
  4. Lenton EA, LM Neal, R Sulaiman “Plasma concentration of human chorionic gonadotropin from the time of implantation until the second week of pregnancy”, Fertil. Steril. 1982; 37(6): 773-778

 

Specifications

Order No. 92215

Qty: 40 Tests

CPT*: 81025, 84703

CLIA: Waived, Non-waived

Contact: (800) 637-3717

Accessories:
92218 : hCG Controls

Clearview hCG Tests Launch Product Demonstration Useful Downloads Product Brochure Package Insert CLSI Procedure (NW)
* It is always the provider's responsibility to establish appropriate coding & charges.